+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Sciatica Drug"

Sciatica Treatment Market Report 2024 - Product Thumbnail Image

Sciatica Treatment Market Report 2024

  • Report
  • December 2024
  • 175 Pages
  • Global
From
Sciatica - Pipeline Insight, 2024 - Product Thumbnail Image

Sciatica - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Sciatica Market Report 2025 - Product Thumbnail Image

Sciatica Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
From
Sciatica - Epidemiology Forecast to 2032 - Product Thumbnail Image

Sciatica - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Sciatica Treatment Market 2023-2027 - Product Thumbnail Image

Sciatica Treatment Market 2023-2027

  • Report
  • August 2023
  • 159 Pages
  • Global
From
From
  • 15 Results (Page 1 of 1)
Loading Indicator

Sciatica is a condition that affects the sciatic nerve, which runs from the lower back down the legs. It is characterized by pain, numbness, and tingling in the lower back, buttocks, and legs. Treatment for sciatica typically involves medications, physical therapy, and lifestyle changes. Central nervous system (CNS) drugs are used to treat a variety of conditions, including sciatica. These drugs work by targeting the brain and spinal cord to reduce pain and inflammation. Common CNS drugs used to treat sciatica include non-steroidal anti-inflammatory drugs (NSAIDs), muscle relaxants, and opioids. The sciatica drug market is a subset of the CNS drug market. It is composed of pharmaceutical companies that specialize in developing and manufacturing drugs to treat sciatica. These companies are typically involved in research and development, clinical trials, and marketing of their products. Some companies in the sciatica drug market include Pfizer, GlaxoSmithKline, Merck, and Novartis. Show Less Read more